News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
784,218 Results
Type
Article (79756)
Company Profile (479)
Press Release (703983)
Multimedia
Podcasts (119)
Webinars (14)
Section
Business (208461)
Career Advice (3579)
Deals (37589)
Drug Delivery (125)
Drug Development (87490)
Employer Resources (183)
FDA (17309)
Job Trends (16336)
News (362030)
Policy (36040)
Tag
Academia (2995)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (96)
Alliances (53136)
ALS (103)
Alzheimer's disease (1502)
Antibody-drug conjugate (ADC) (159)
Approvals (17270)
Artificial intelligence (308)
Autoimmune disease (29)
Automation (16)
Bankruptcy (361)
Best Places to Work (12519)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (340)
Bladder cancer (85)
Brain cancer (32)
Breast cancer (313)
Cancer (2470)
Cardiovascular disease (204)
Career advice (3039)
Career pathing (34)
CAR-T (176)
Cell therapy (495)
Cervical cancer (22)
Clinical research (70564)
Collaboration (932)
Company closure (2)
Compensation (566)
Complete response letters (29)
COVID-19 (2850)
CRISPR (50)
C-suite (275)
Cystic fibrosis (109)
Data (2360)
Decentralized trials (2)
Denatured (42)
Depression (56)
Diabetes (296)
Diagnostics (6850)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (133)
Drug pricing (129)
Drug shortages (33)
Duchenne muscular dystrophy (104)
Earnings (79672)
Editorial (47)
Employer branding (23)
Employer resources (158)
Events (125340)
Executive appointments (787)
FDA (18733)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (828)
Gene editing (125)
Generative AI (30)
Gene therapy (364)
GLP-1 (843)
Government (5139)
Grass and pollen (6)
Guidances (150)
Healthcare (20794)
Huntington's disease (26)
IgA nephropathy (30)
Immunology and inflammation (148)
Indications (30)
Infectious disease (3011)
Inflammatory bowel disease (158)
Inflation Reduction Act (11)
Influenza (57)
Intellectual property (102)
Interviews (692)
IPO (17459)
IRA (51)
Job creations (4286)
Job search strategy (2495)
Kidney cancer (10)
Labor market (42)
Layoffs (557)
Leadership (24)
Legal (8474)
Liver cancer (80)
Lung cancer (347)
Lymphoma (159)
Machine learning (9)
Management (63)
Manufacturing (354)
MASH (80)
Medical device (14352)
Medtech (14357)
Mergers & acquisitions (20733)
Metabolic disorders (793)
Multiple sclerosis (88)
NASH (23)
Neurodegenerative disease (116)
Neuropsychiatric disorders (33)
Neuroscience (2112)
NextGen: Class of 2025 (7483)
Non-profit (5064)
Now hiring (38)
Obesity (426)
Opinion (274)
Ovarian cancer (83)
Pain (105)
Pancreatic cancer (90)
Parkinson's disease (161)
Partnered (22)
Patents (256)
Patient recruitment (118)
Peanut (51)
People (63190)
Pharmaceutical (96)
Pharmacy benefit managers (22)
Phase I (22049)
Phase II (30806)
Phase III (22965)
Pipeline (1393)
Policy (180)
Postmarket research (3142)
Preclinical (9909)
Press Release (71)
Prostate cancer (114)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (435)
Real estate (6764)
Recruiting (72)
Regulatory (24773)
Reports (42)
Research institute (2645)
Resumes & cover letters (557)
Rett syndrome (5)
RNA editing (5)
RSV (48)
Schizophrenia (81)
Series A (144)
Series B (94)
Service/supplier (18)
Sickle cell disease (59)
Special edition (20)
Spinal muscular atrophy (163)
Sponsored (34)
Startups (3925)
State (2)
Stomach cancer (16)
Supply chain (73)
Tariffs (51)
The Weekly (75)
Vaccines (807)
Venture capitalists (45)
Weight loss (297)
Women's health (41)
Worklife (20)
Date
Last 7 days (971)
Last 30 days (3106)
Last 365 days (34473)
2025 (12470)
2024 (37427)
2023 (42183)
2022 (53514)
2021 (58381)
2020 (57239)
2019 (50970)
2018 (38787)
2017 (35840)
2016 (36241)
2015 (42267)
2014 (35971)
2013 (32155)
2012 (33846)
2011 (34052)
2010 (33250)
Location
Africa (1135)
Alabama (61)
Alaska (7)
Arizona (232)
Arkansas (14)
Asia (46082)
Australia (8208)
California (6588)
Canada (2094)
China (569)
Colorado (284)
Connecticut (305)
Delaware (162)
Europe (106748)
Florida (970)
Georgia (226)
Hawaii (1)
Idaho (63)
Illinois (627)
India (28)
Indiana (339)
Iowa (12)
Japan (177)
Kansas (113)
Kentucky (27)
Louisiana (13)
Maine (70)
Maryland (972)
Massachusetts (5044)
Michigan (249)
Minnesota (422)
Mississippi (2)
Missouri (91)
Montana (31)
Nebraska (26)
Nevada (68)
New Hampshire (70)
New Jersey (1858)
New Mexico (31)
New York (1871)
North Carolina (1109)
North Dakota (9)
Northern California (2866)
Ohio (222)
Oklahoma (15)
Oregon (39)
Pennsylvania (1447)
Puerto Rico (14)
Rhode Island (34)
South America (1493)
South Carolina (25)
South Dakota (1)
Southern California (2459)
Tennessee (107)
Texas (976)
United States (25131)
Utah (199)
Virginia (163)
Washington D.C. (71)
Washington State (601)
West Virginia (3)
Wisconsin (69)
784,218 Results for "the research institute of the mcgill university health centre".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Flagship Pioneering, Cambridge University Health Partners, and Milner Therapeutics Institute Announce Collaboration to Accelerate Biotech Research and Innovation
January 23, 2025
·
5 min read
Press Releases
QIAGEN collaborates with McGill University to advance microbiome research
November 13, 2024
·
8 min read
Press Releases
Cognition Therapeutics Presented Data at Association for Research in Vision and Ophthalmology Showing Impact on Retinal Cell Health
May 9, 2025
·
8 min read
Press Releases
Breakthrough T1D Awards $2.8 Million in Funding to Expand Center of Excellence at University of Michigan and Oregon Health & Science University to Accelerate Type 1 Diabetes Research
April 24, 2025
·
5 min read
Press Releases
Genprex Signs Sponsored Research Agreement with the University of Pittsburgh to Study Diabetes Gene Therapy in Type 1 and Type 2 Diabetes
May 7, 2025
·
8 min read
Diabetes Researchers in China Demonstrate Early Insulin Therapy Significant Benefits Cardiovascular Health
Recently, Professor Jianping Weng of the University of Science and Technology of China and President of Anhui Medical University and his team of researchers from USTC, Southern Medical University and Peking University published the results of their latest research on the effects of early insulin therapy on cardiovascular health in adults with Type 2 Diabetes Mellitus in the journal Signal Transduction and Targeted Therapy.
June 19, 2024
·
6 min read
Pharm Country
Renal Research Institute and Karolinska Institutet announce chronic kidney disease management symposium, highlighting new therapeutics
Renal Research Institute, a global leader in dialysis and nephrology research and a subsidiary of Fresenius Medical Care AG, announced together with the Karolinska Institutet a joint symposium, “Prevention of CKD progression: the impact of new therapeutics.” The Karolinska Institutet is one of the world’s leading medical universities.
May 17, 2024
·
3 min read
Press Releases
Breaking new ground in mental health research: Oxford University, Boehringer Ingelheim, and Cumulus Neuroscience launch first of its kind study investigating the day-to-day experience of patients with psychiatric disorders
April 30, 2025
·
8 min read
Pharm Country
PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
PAVmed Inc announced that Veris and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, a National Cancer Institute-Designated Comprehensive Cancer Center, launched a pilot program and enrolled the first patients on the Veris Cancer Care Platform™ pursuant to a recently-executed memorandum of understanding.
June 13, 2024
·
5 min read
Press Releases
Transneural Therapeutics Appoints CNS Drug Development Expert, Mark A. Demitrack, MD, as Chief Research and Development Officer
April 29, 2025
·
3 min read
1 of 78,422
Next
